Neumann Advisory Hong Kong Ltd - SINOVAC BIOTECH LTD ownership

SINOVAC BIOTECH LTD's ticker is SVA and the CUSIP is P8696W104. A total of 10 filers reported holding SINOVAC BIOTECH LTD in Q4 2022. The put-call ratio across all filers is - and the average weighting 1.2%.

Quarter-by-quarter ownership
Neumann Advisory Hong Kong Ltd ownership history of SINOVAC BIOTECH LTD
ValueSharesWeighting
Q3 2023$2,0420.0%315,5860.0%0.82%
+5.5%
Q2 2023$2,0420.0%315,5860.0%0.78%
-13.0%
Q1 2023$2,0420.0%315,5860.0%0.90%
-28.7%
Q4 2022$2,0420.0%315,5860.0%1.26%
+75.4%
Q3 2022$2,0420.0%315,5860.0%0.72%
+6.7%
Q2 2022$2,0420.0%315,5860.0%0.67%
+48.8%
Q1 2022$2,0420.0%315,5860.0%0.45%
+27.8%
Q4 2021$2,0420.0%315,5860.0%0.35%
-3.0%
Q3 2021$2,0420.0%315,5860.0%0.36%
+11.0%
Q2 2021$2,0420.0%315,5860.0%0.33%
-8.9%
Q1 2021$2,0420.0%315,5860.0%0.36%
-6.7%
Q4 2020$2,042
-99.9%
315,5860.0%0.39%
-25.3%
Q3 2020$2,042,0000.0%315,5860.0%0.52%
-23.6%
Q2 2020$2,042,0000.0%315,5860.0%0.68%
-37.7%
Q1 2020$2,042,0000.0%315,5860.0%1.09%
+5.5%
Q4 2019$2,042,000
+99900.0%
315,5860.0%1.03%
-13.7%
Q3 2019$2,0420.0%315,5860.0%1.19%
+5.4%
Q2 2019$2,0420.0%315,5860.0%1.13%
+4.1%
Q1 2019$2,042
-6.8%
315,5860.0%1.09%
-28.5%
Q4 2018$2,190
-23.3%
315,586
-15.7%
1.52%
-9.5%
Q3 2018$2,854
-99.9%
374,508
-7.0%
1.68%
+3.7%
Q2 2018$3,005,000
-13.4%
402,8440.0%1.62%
-20.4%
Q1 2018$3,469,000
+9.3%
402,8440.0%2.04%
-3.8%
Q4 2017$3,174,000402,8442.12%
Other shareholders
SINOVAC BIOTECH LTD shareholders Q4 2022
NameSharesValueWeighting ↓
Orbimed Advisors 2,718,735$340,000,0007.22%
Vivo Capital, LLC 5,900,000$38,173,0004.18%
Neumann Advisory Hong Kong Ltd 315,586$2,0420.82%
Financial Gravity Asset Management, Inc. 988$3,197,6860.04%
Yorktown Management & Research Co Inc 149,786$4,4940.01%
Renaissance Technologies 2,375,841$1,5370.00%
WELLS FARGO & COMPANY/MN 1,661$10,7470.00%
NORTHERN TRUST CORP 13,787$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 412$2,6660.00%
View complete list of SINOVAC BIOTECH LTD shareholders